Vaping Being Protected from FDA Bans

Posted by Jared on

The American Vaping Association (AVA), an established advocate of vaping benefits, has praised several agencies for approving a spending bill that would effectively protect the vaping industry from bankruptcy. These agencies, including the House of Appropriations Subcommittee on Agriculture, blocked the Food and Drug Administration Center for Tobacco from requiring a multibillion dollar Premarket Tobacco Review process. This bill will not affect the agency's ability to regulate products and market standards, but, without the bill, many businesses fear they will go bankrupt due to increased costs that would be associated with the new review requirements.

Vaping has been praised by advocates like the AVA for its ability to wean former smokers off of addictive and nicotine-laden habits and provide them with an alternative satisfaction without the negative side-effects, such as withdrawal symptoms. By attracting more smokers to convert to vapor, businesses argue they are reducing the amount of traditional tobacco products being consumed. Furthermore, the most popular vaping liquids are sold at nicotine concentrations below cigarette standards; many consumers purchase liquids with no nicotine at all, enjoying the sensation of vaping without any chemical effects. Secondhand smoke has been proven to be less harmful from vaping devices than traditional cigarettes, thereby reducing any possible exposure to toxins that non-smokers might encounter. It's reasons like these that the AVA and vaping industries are fighting to keep these products afloat, especially with an impending ruling that could return a large part of the "smoking" industry back to the Big Tobacco companies.

The spending bill being proposed would not stop the FDA from its regulating capacity but rather it would stop possible product bans. Passing the spending bill would prevent FDA from taking retroactive steps by requiring products which are already being marketed to go through Premarket Tobacco Review applications. The associated costs would surely result in financial disaster for all operations not associated with Big Tobacco companies, the same big companies who have capitalized on the wealth of the smoking market for generations. Its also these big companies who would like to see their competition be eliminated by such an expensive review process requirement.

It was last April that the new FDA regulation concept was proposed. Advocates of both the gaping industry as well as of public health began emphasizing how this concept could potentially remove more than 99% of the existing vapor products from the market. Such a large scale ban would merely be the result of small product manufacturers' inability to front the hefty associated costs of the new review process. By November, after the House indicated Congress could act on the issue if the FDA did not address it, several Representatives wrote to the Secretary of Health & Human Services to request the adoption of the regulation. In response, the AVA, through the voice of President Gregory Conley, issued a statement in support of the vaping industry.

The AVA, which operates as a nonprofit organization, advocates small business success in e-cigarette and related industries. Recognizing the negative impact that this new regulation would have on such ventures, as well as the ability for vaping products to assist smokers in the quitting process, Conley stated that passing the regulation "would be a disaster not only for thousands of small businesses, but also public health." Furthermore, he argues that it would be an unreasonable decision to ban thousands of vaping products when sales of traditional cigarettes, with their notorious health drawbacks, remain unaffected. Not only would passing such a regulation have a deleterious effect on the success of these new ventures, it would negatively impact the healthier direction that modern alternatives to smoking are taking.

As it stands, the vaping industry continues to operate strongly, providing numerous kinds of safer nicotine - or even nicotine-free - products to its customers. A growing number of research papers and literature have been documenting the positive effects of supporting the industry, including the ability to assist smokers who want to quit. This increasing evidence will surely remain useful in the arguments to block any future actions the FDA may make with the hopes of unfairly handing back the profits of small vaping companies to the historic kings of the American tobacco industry.

If you'd like to find out more more about this news or news like this you can find it here at the AVA's site:

Share this post

← Older Post Newer Post →